04-11-2021 17:36 via wallstreet-online.de

Oncopeptides Reduces Clinical Development Program with Melflufen

(PLX AI) – Oncopeptides focuses clinical development efforts to increase cash runwayOncopeptides reduces the activity level in the clinical development program with melflufen
Weiterlesen »